Hepatocellular carcinoma
- PMID: 22863046
- DOI: 10.1016/S0140-6736(12)61285-9
Hepatocellular carcinoma
Comment on
-
Hepatocellular carcinoma.Lancet. 2012 Mar 31;379(9822):1245-55. doi: 10.1016/S0140-6736(11)61347-0. Epub 2012 Feb 20. Lancet. 2012. PMID: 22353262 Review.
Similar articles
-
Fibrolamellar hepatocellular carcinoma.Indian J Gastroenterol. 1994 Oct;13(4):148-9. Indian J Gastroenterol. 1994. PMID: 7829150
-
[Liver transplantation for hepatocellular carcinoma].Nihon Shokakibyo Gakkai Zasshi. 2006 Feb;103(2):156-61. Nihon Shokakibyo Gakkai Zasshi. 2006. PMID: 16506663 Review. Japanese. No abstract available.
-
[Liver resection in the treatment of hepatocellular carcinoma].Gastroenterol Hepatol. 2001 Dec;24(10):511-3. Gastroenterol Hepatol. 2001. PMID: 11730622 Spanish. No abstract available.
-
[Liver transplantation for hepatocellular carcinoma].Pol Arch Med Wewn. 2003 Sep;110(3):1025-31. Pol Arch Med Wewn. 2003. PMID: 14699697 Review. Polish. No abstract available.
-
Liver transplantation for hepatocellular carcinoma--is it worth it?Mayo Clin Proc. 1994 Jun;69(6):599-600. doi: 10.1016/s0025-6196(12)62255-1. Mayo Clin Proc. 1994. PMID: 8189769 No abstract available.
Cited by
-
Association between underexpression of microrna-203 and clinicopathological significance in hepatocellular carcinoma tissues.Cancer Cell Int. 2015 Jun 18;15:62. doi: 10.1186/s12935-015-0214-0. eCollection 2015. Cancer Cell Int. 2015. PMID: 26109910 Free PMC article.
-
Excessive intraoperative blood loss independently predicts recurrence of hepatocellular carcinoma after liver transplantation.BMC Gastroenterol. 2015 Oct 15;15:138. doi: 10.1186/s12876-015-0364-5. BMC Gastroenterol. 2015. PMID: 26472203 Free PMC article.
-
Role of CD147 in the development and diagnosis of hepatocellular carcinoma.Front Immunol. 2023 Apr 6;14:1149931. doi: 10.3389/fimmu.2023.1149931. eCollection 2023. Front Immunol. 2023. PMID: 37090718 Free PMC article. Review.
-
Sorafenib-Entrapped, Self-Assembled Pullulan-Stearic Acid Biopolymer-Derived Drug Delivery System to PLC/PRF/5 Hepatocellular Carcinoma Model.Int J Nanomedicine. 2022 Oct 31;17:5099-5116. doi: 10.2147/IJN.S377354. eCollection 2022. Int J Nanomedicine. 2022. PMID: 36340185 Free PMC article.
-
OCIAD2 suppressed tumor growth and invasion via AKT pathway in Hepatocelluar carcinoma.Carcinogenesis. 2017 Sep 1;38(9):910-919. doi: 10.1093/carcin/bgx073. Carcinogenesis. 2017. PMID: 28911005 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical